Clinical trials
Staging clinical trials
Below are recruiting staging clinical trials, each written for real people, not researchers. We’re tracking 1,854 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06514118Recruiting
Immunotherapy with radiation for advanced small-cell lung cancer
This trial tests a combination of chemotherapy, immunotherapy, and targeted radiation for people with extensive-stage small-cell lung cancer. The goal is to see if adding radiation to leftover tumors after initial treatment helps control the disease better.
Qingdao, ShandongAges 18–80 - NCT07793929RecruitingPhase 1
Kidney function and study drug levels
This study checks how different levels of kidney function affect the levels of a new investigational drug called Ribupatide in the blood. It helps doctors understand how the drug works in people with various kidney conditions.
Orlando, FloridaAges 18–85 - NCT04837859RecruitingPhase 2
Personalized immunotherapy for early-stage unfavorable Hodgkin lymphoma
This trial studies a customized immune-based treatment approach for people with early-stage “unfavorable” classical Hodgkin lymphoma who have not had prior treatment. It may help by targeting your lymphoma using an individualized plan based on your case.
CologneAges 18 years+ - NCT07796880RecruitingPhase 2
Study of a new drug with hormone therapy before breast cancer surgery
This trial tests a new drug called culmerciclib when given with hormone therapy before breast cancer surgery. The goal is to see if this combination can shrink tumors and improve outcomes for patients with hormone-receptor-positive, HER2-negative breast cancer.
Guangzhou, GuangdongAges 18–70 - NCT06525909Recruiting
Immune status in chronic hepatitis B
This study looks at how the immune system changes over time in people with chronic hepatitis B. It will help doctors better understand the stages of the disease to guide treatment decisions.
Wuhan, HubeiAges 18–50 - NCT06528847RecruitingPhase 2
Adjuvant Benmelstobart for stage IB, grade 3 lung adenocarcinoma
This trial tests whether giving the immunotherapy drug Benmelstobart after surgery can help prevent return of a specific type of lung cancer. It is for people with stage IB, grade 3 (poorly differentiated) lung adenocarcinoma that has been completely removed.
Shanghai, Shanghai MunicipalityAges 18–74 - NCT06533267Recruiting
Endoscopic surgery vs. radiation for early-stage nasal cancer
This trial compares two treatments for stage I nasopharyngeal cancer (a type of nasal cancer). It tests whether a minimally invasive surgery (endoscopic surgery) is as good as or better than radiation therapy. It may be an option for people whose cancer is small and hasn't spread to lymph nodes.
Zhuhai, GuangdongAges 18–75 - NCT04679454Recruiting
One-dose pre-surgery radiation for early breast cancer
This study tests whether giving a single dose of radiation before breast surgery can be safe and effective for early-stage breast cancer. It may help by shrinking or treating the tumor right before the operation, depending on your case.
MilanAges 18 years+ - NCT07792317Recruiting
Cold storage treatment for donated kidneys before transplant
This study tests a special cold storage solution and machine to keep donated kidneys healthy before they are transplanted. It may help the kidneys work better after surgery.
RotterdamAges 18 years+ - NCT05642013Recruiting
Short interval exchange surgery for infected hip or knee implants
This study compares how to replace an infected hip or knee implant using a two-step surgery with a shorter waiting time. It aims to reduce the time between surgeries while still safely treating the infection.
MontpellierAges 18 years+ - NCT06543108Recruiting
Comparing two PET scans for stomach cancer
This study compares two types of PET scans (FAPI and FDG) to see which one works better for diagnosing stomach cancer. You would receive both scans within a week, and your doctor would also check your blood for tumor markers.
Changsha, HunanAges 18–90 - NCT07778316RecruitingPhase 3
Tarlatamab for small cell lung cancer after first chemotherapy
This trial tests a new drug called tarlatamab, given either as an injection under the skin or through an IV, for people with extensive-stage small cell lung cancer that has grown or come back after one round of chemotherapy. The goal is to see which way of giving the drug works better and is safer.
Orlando, FloridaAges 18–99 - NCT07781098Recruiting
Radiation therapy for early-stage voice box cancer with poor differentiation
This trial studies whether adding radiation therapy after surgery can help people with early-stage voice box cancer that has poor differentiation (cells look very abnormal). It aims to improve outcomes for this specific type of cancer.
Hangzhou, ZhejiangAges 18 years+ - NCT07779109Recruiting
Shorter radiation course for endometrial cancer after surgery
This study tests a shorter, more intense course of radiation therapy after surgery for endometrial cancer. It aims to see if it is safe and works as well as standard radiation, while possibly reducing treatment time.
Zaragoza, ZaragozaAges 18–110 - NCT07781085Recruiting
Radiation therapy after surgery for early glottic cancer
This study looks at whether adding radiation therapy after surgery improves outcomes for people with early-stage glottic cancer that involves the anterior commissure (the front part of the vocal cords). If you join, you may receive radiation therapy or not, and the researchers will compare the results.
Hangzhou, ZhejiangAges 18 years+ - NCT06559761Recruiting
Imaging to predict liver cancer aggressiveness after surgery
This study looks at whether special scans can help doctors better predict how aggressive a person's liver cancer (hepatocellular carcinoma) will be, especially right after surgery. If you are planning to have surgery to remove the tumor as your first treatment, this trial might be a good fit.
Beijing, Beijing MunicipalityAges 18–80 - NCT06562920RecruitingPhase 2
Immunotherapy plus chemo and SBRT before surgery for limited-stage small cell lung cancer
This trial tests a combination of immunotherapy (adebrelimab), chemotherapy, and targeted radiation (SBRT) before surgery for people with limited-stage small cell lung cancer. The goal is to see if this approach can shrink tumors and improve outcomes before the main treatment.
Hangzhou, ZhejiangAges 18–75 - NCT06561620RecruitingPhase 4
Befotertinib after surgery for early-stage lung cancer
This trial tests a pill called befortinib for people with early-stage lung cancer who have had surgery. It aims to lower the chance of the cancer coming back. You might qualify if your tumor had certain high-risk features and you still have cancer DNA in your blood after surgery.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07767500Recruiting
MRI-guided radiation therapy for early-stage kidney cancer
This trial tests a new way to deliver radiation to kidney tumors using MRI guidance. It aims to treat early-stage kidney cancer while sparing healthy tissue, and may be an option for people who cannot have surgery or prefer not to.
New York, New YorkAges 18 years+ - NCT07770100RecruitingPhase 2
Matching immunotherapy and targeted radiation for advanced cancer
This trial tests combining immunotherapy (a treatment that boosts your immune system to fight cancer) with a targeted type of radiation called SBRT, which precisely delivers high-dose radiation to multiple cancer spots. The main goal is to see if this combination helps control metastatic cancer (cancer that has spread) better than standard care.
Lexington, KentuckyAges 18–99 - NCT07770256Recruiting
Bone regeneration surgery for lower molar gum disease
This study looks at the shape of lower molar teeth with a certain type of gum disease and tests a surgical treatment to help regrow the bone around those teeth. If you have advanced gum disease and a lower molar with a specific type of bone loss, this treatment might help save the tooth.
Ho Chi Minh CityAges 18 years+ - NCT07769827Recruiting
Peginterferon alfa-2b for advanced liver cancer with hepatitis B
This study tests a drug called peginterferon alfa-2b for people with advanced liver cancer that cannot be removed by surgery and who also have hepatitis B. The drug aims to boost the immune system to fight the cancer and may help control the disease.
Nanjing, JiangsuAges 18 years+ - NCT06501391RecruitingPhase 2
Brain radiation plus chemo-immunotherapy for untreated NSCLC with stable brain metastases
This trial tests whether combining brain radiation with chemotherapy and immunotherapy can help people with advanced lung cancer that has spread to the brain but has not yet been treated. It is for those whose tumors do not have certain gene mutations (EGFR, ALK, ROS1).
ShanghaiAges 18 years+ - NCT06574698Recruiting
Adding Naxitamb to high-risk neuroblastoma treatment
This trial is for children with high-risk neuroblastoma, a type of nerve cell cancer. It tests adding a new medicine called Naxitamb to standard induction therapy to see if it works better. High-risk means the cancer is advanced or has certain aggressive features.
Guanzhou, GuangdongAges 1–21
Hear when a new Staging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for staging?
- Yes. Clin2 currently lists 1,854 recruiting staging studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a staging trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a staging trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.